Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on May 6, 2026

May 6, 2026

Mesothelioma Victims Center Appeals to a Plumber or Construction Worker with Mesothelioma or Asbestos Lung Cancer to Call Them for Direct Access to The Top Compensation Lawyers in the USA-Not a Law Firm Call Center

Indeterminate EIN Presswire

May 6, 2026

Smartpatient und Cancer Support Community kooperieren, um die Unterstützung bei Brust- und Prostatakrebs zu verbessern

Indeterminate EIN Presswire

May 6, 2026

Dr. Austin Harris Introduces Advanced Neuromodulation Protocols for Complex Neuropsychiatric and Chronic Pain Cases

Indeterminate EIN Presswire

May 6, 2026

Gala Health Under Investigation: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support

Indeterminate GlobeNewswire

May 6, 2026

Alpha Honey Gummies Claims Evaluated: The AlphaHoney Male Enhancement Ingredients for Virility-Enhancing Performance Support

Indeterminate GlobeNewswire

May 6, 2026

Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference

Indeterminate GlobeNewswire

May 6, 2026

Precipio Announces Q1-2026 Shareholder Update Call

Indeterminate GlobeNewswire

May 6, 2026

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

Indeterminate GlobeNewswire

May 6, 2026

Vireo Growth Inc. to Release First Quarter Results on May 12, 2026

Indeterminate GlobeNewswire

May 6, 2026

Knight Therapeutics Inc. announces voting results from the Annual General Meeting

Indeterminate GlobeNewswire

May 6, 2026

Thérapeutique Knight annonce les résultats du vote de l’assemblée générale annuelle

Indeterminate GlobeNewswire

May 6, 2026

argenx to Present at BofA Securities 2026 Health Care Conference

Indeterminate GlobeNewswire

May 6, 2026

Alvotech Q1 2026 Financial Results

Indeterminate GlobeNewswire

May 6, 2026

Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026

Indeterminate GlobeNewswire

May 6, 2026

Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference

Indeterminate GlobeNewswire

May 6, 2026

Bionano Announces Leadership Transition

Indeterminate GlobeNewswire

May 6, 2026

Context Therapeutics Reports First Quarter 2026 Operating and Financial Results

Indeterminate GlobeNewswire

May 6, 2026

Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026

Indeterminate GlobeNewswire

May 6, 2026

HCI Group Reports First Quarter 2026 Results

Indeterminate GlobeNewswire

May 6, 2026

DLH Reports Fiscal 2026 Second Quarter Results

Indeterminate GlobeNewswire